Clinical trial · Observational
The Value of a Convolutional Neural Network-Based Renal Artery Perfusion Model in Predicting Renal Function After Partial Nephrectomy: A Prospective Study
The Value of a Renal Artery Perfusion Model Based on Convolutional Neural Network in Predicting Renal Function After Partial Nephrectomy: A Prospective, Single-Center Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to develop a CNN-based machine module to predict postoperative fractional renal function in people who are proposed to undergo partial nephrectomy. The main question it aims to answer is: • Does this machine learning model accurately predict renal function after partial nephrectomy?
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Renal Cell Cancer | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- GFR of ipsilateral and contralateral kidneys
- timeFrame
- 3 months after surgery
- measure
- volume of ipsilateral kidney
- timeFrame
- 3 months after surgery
Secondary outcomes (1)
- measure
- Postoperative total renal function(eGFR)
- timeFrame
- 24 hours, 1 month, 3 months, 6 months, 1 year after surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * people with stage cT1 renal tumors confirmed by preoperative CT or MR * people who are proposed to undergoing partial nephrectomy * localized renal tumors without lymph node and distant metastases as defined by NCCN guidelines * ECOG score of 0 or 1 * Life expectancy greater than 10 years Exclusion Criteria: * people with surgically unresectable lesions * people with Abnormal preoperative renal function, eGFR(estimated by CKD-EPI)\<90ml/min/1.73m2 * people who receive preoperative molecular targeted therapy, immunotherapy, chemotherapy * people with any contraindications to surgery * people who convert to radical nephrectomy during surgery * people who receive molecular targeted therapy, immunotherapy or chemotherapy during the postoperative follow-up period * people with serious systemic disease
References
Publications (0)
Data not yet available